Liver Injury Biomarkers in Pediatric Metabolic Syndrome: Key Biochemical Associations
Teofana-Otilia Bizerea-Moga, Tudor Voicu Moga, Sanja Panic Zaric, Rade Vukovic, Otilia Mărginean, Lazăr Chișavu

TL;DR
This study finds that liver enzymes are more strongly linked to triglyceride levels in children with metabolic syndrome and fatty liver disease, suggesting a close connection between fat metabolism and liver damage.
Contribution
The study identifies stronger correlations between liver enzymes and triglycerides in children with metabolic syndrome and MAFLD compared to general populations.
Findings
Alanine aminotransferase showed a significant positive correlation with triglycerides in children with metabolic syndrome and MAFLD.
Aspartate aminotransferase also showed increased correlation with triglycerides in children with MAFLD.
The findings suggest metabolic dysregulation, not just obesity, drives liver damage in children.
Abstract
Background: The presence of metabolic syndrome (MetS) in children predisposes them to steatotic liver disease, with or without liver enzyme alterations. Early diagnosis of the degree of liver damage can stop the progression to more severe dysfunction. Objectives: This study aimed to establish the link between liver enzyme levels and triglyceride and cholesterol values in pediatric patients with obesity, grouped according to MetS status and metabolic dysfunction-associated fatty liver disease (MAFLD). Methods: The retrospective observational study included 261 pediatric patients aged between 0 and 18 years diagnosed with obesity, MetS, and MAFLD. Before initiating the study, approval was obtained from the hospital’s Ethics Committee. The clinical and biochemical data were collected from the patients’ histories. Results: Alanine aminotransferase showed a significant positive correlation…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLiver Disease Diagnosis and Treatment · Liver Disease and Transplantation · Diabetes, Cardiovascular Risks, and Lipoproteins
